Podcasts about md ceo

In this illuminating episode of the Self-Care Goddess Podcast, I sit down with Dr. Larry Weiss, MD—CEO and founder of Symbiome Skincare and a pioneer in microbiome science—to explore how our mighty microbiome shapes everything from our skin health to aging, immunity, and overall resilience.Dr. Weiss takes us on a fascinating journey from the Amazon rainforest to the modern skincare lab, revealing how reconnecting with the microbial world can restore our health, balance, and beauty.✨ Here's what you'll learn in this empowering conversation:✅ What your microbiome really is—and why it's essential to your health and longevity✅ How modern lifestyles have depleted our natural resilience and disrupted the skin microbiome✅ The link between gut health, skin health, and inflammation✅ How fermented foods and probiotic skincare can help rebuild your inner and outer ecosystem✅ Why your skin is a mirror of your overall wellbeing✅ The truth about hand sanitizers, hygiene, and microbiome balance✅ How Symbiome's fermented skincare works with nature—not against it—to restore your skin's natural vitality✅ Dr. Weiss's top 3 self-care rituals for daily health, joy, and connection

Send us a textDr. Adam Rogers, MD is Chief Executive Officer of NervGen Pharma Corp. ( https://nervgen.com/ ) a clinical-stage biotech company dedicated to developing innovative treatments to enable nervous system repair in the settings of traumatic injury and disease. NervGen's lead drug candidate, NVG-291, is being evaluated in mid stage clinical trials in an initial target indication, spinal cord injury. NervGen has initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury.Dr. Rogers is a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous, and previously co-founded and served as CEO of Hemera Biosciences, a clinical stage gene therapy biotech company targeting dry age-related macular degeneration where he oversaw all aspects of the company until the Hemera assets were acquired in December 2020 by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.From 2001 to 2020 Dr. Rogers served as an Assistant Professor of Ophthalmology at the New England Eye Center of Tufts Medical Center (Boston, MA). Dr. Rogers has published 29 articles in peer reviewed journals and co-authored two textbooks and numerous chapters in major ophthalmic textbooks. Since 2007 he has served on the board of One Family Inc., an organization whose mission is to end homelessness in Massachusetts. He is a member of the Emory University Board of Trustees. Dr. Rogers has a MD from Emory College and Emory School of Medicine.#SpinalCordInjury #SCI #IschemicStroke #AmyotrophicLateralSclerosis #ALS #NervGen #Rehabilitation #RegenerativeMedicine #RegenerativeBiology #ChondroitinSulfateProteoglycans #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Send us a textDr. Jacob Lalezari, MD is the Chief Executive Officer of CytoDyn ( https://www.cytodyn.com/ ), a biopharma company committed to enhancing the lives of patients through target specific medicine and a next generation of monoclonal antibody therapeutics. CytoDyn's team is focused on developing leronlimab, a monoclonal antibody CCR5 receptor antagonist, to be used as a platform drug for a variety of indications. Dr. Lalezari brings over 34 years of industry experience to CytoDyn, including nearly 20 years of experience with leronlimab, also known as PRO 140, and he previously served as interim CEO and Chief Medical Officer and has been a member of the Company's scientific advisory board for the past several years.  Dr. Lalezari has previously served as the CEO and Medical Director of Quest Clinical Research and served as the Chief Medical Officer of Virion Therapeutics. Dr. Lalezari has served as Principal Investigator for Phase I, II, and III clinical studies of new therapies for such viral diseases as HIV/AIDS, CMV, HPV, HSV, Hepatitis B and C, influenza, RSV, and COVID-19, including clinical trials conducted by the Company. His work has been published extensively and he is a well-regarded international speaker and patient advocate. Dr. Lalezari received his M.D. from the University of Pennsylvania, his M.A. from the University of Virginia, and his B.A. from the University of Rochester. He also holds a board certification from the American Board of Internal Medicine.#JacobLalezari #Cytodyn #MonoclonalAntibody #Leronlimab #CCR5Receptor #CCR5Antagonist #ChemokineReceptor5 #HIV #AutoimmuneDisorders #HIVCoReceptor #Macrophages #DendriticCells #TripleNegativeBreastCancer #TLymphocytes #MetastaticColorectalCancer #PD1 #ProgrammedCellDeathProtein1 #Oncology #Immunooncology #Cancer #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textDr. Marc Salzberg, MD is President, Chief Executive Officer & Chief Medical Officer of Airway Therapeutics ( https://www.airwaytherapeutics.com/ ), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases.Dr. Salzberg has more than 25 years of academic and pharmaceutical experience in the management of drug development and clinical research, including medical management of anti-viral drugs clinical development and market introduction including saquinavir and ganciclovir. He spent several years at Roche's headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).During his career, Dr. Salzberg has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.Dr. Salzberg earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.#MarcSalzberg #AirwayTherapeutics #HumanSurfactantProteinD #Collectin #PathogenRecognition #RespiratoryDiseases  #InflammatoryResponse #BronchopulmonaryDysplasia #ZelpultideAlfa #Covid #Asthma #COPD #Influenza #RSV #ARDS #AcuteRespiratoryDistressSyndrome #ChronicObstructivePulmonaryDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textDr. Samir Khleif, MD is CEO of Georgiamune ( https://www.georgiamune.com/team ), a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.  Dr. Khleif is a pioneer in the field of immunotherapy. He is a medical oncologist, immunologist, innovator, and entrepreneur, as well as a transformational executive in health care and biomedical research.Prior to becoming CEO of Georgiamune, Dr. Khleif served in different academic and leadership positions. He was a National Cancer Institute (NCI)/National Institutes of Health (NIH) scientist and Chief of the NCI Cancer Vaccine Section, where he led the development of pioneering immune-oncology and cancer vaccines into clinical trials. As a national and international academic leader, and detailed by the US government, he served as the founding director and CEO of the King Hussein Cancer Center ( https://www.khcc.jo/en ) in Amman, Jordan, where he led the development of the largest cancer center in the MENA region. He also served as the director of the Georgia Cancer Center, the state cancer center, at Augusta University. He is currently a biomedical scholar and holds a professorship at Georgetown University Medical School.Dr. Khleif also served as a Special Assistant to the Commissioner of the FDA, leading the FDA's Critical Path Initiative for Oncology. He is a member of the board of directors of Ayala Pharmaceuticals and Emerald Biopharmaceutics, and served as a member of the scientific advisory board of more than 20 biotechnology and pharmaceutical companies.Dr. Khleif is an international KOL in immunology and immunotherapy. He has served on many national committees, including the Scientific Advisory Board of the Biden Cancer Initiative, as chair of the Immunotherapy Committee for NRG, and as a member of the NCI Cooperative Group. He currently serves as an advisor for the Parker Institute for Cancer Immunotherapy. Dr. Khleif is an editor of three books, the author of hundreds of peer-reviewed scientific research articles, and a prolific inventor with more than 150 patents issued or pending in the field of immunology and immunotherapy.Dr. Khleif received his medical degree at the University of Jordan, Amman Jordan. He completed his residency in Internal Medicine at the Medical College of Ohio and his fellowship in Medical Oncology at the National Cancer Institute (NCI) in Bethesda, Maryland.#SamirKhleif #Georgiamune #Immunotherapy #KingHusseinCancerCenter #CriticalPathInitiative #FDA #Tregs #RegulatoryTCells #Cancer #Oncology #CheckpointInhibitors #ImmuneEscapeMechanisms #DualFunctioningAntibody #Autoimmune #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

In this episode, Oluwakayode and The Guru analyzed news stories from different newspaper front pages.

In our International Women's Day Series, we interviewed powerful women who took us through their journeys, challenges, and triumphs—celebrating resilience, leadership, and impact.

Send us a textDr. Hernan A. Bazan MD, FACS, CEO & Co-Founder of South Rampart Pharma, Inc. ( https://southrampartpharma.com/about-us/hernan-bazan/ ), a clinical stage biopharma company developing safer, non-opioid therapies for acute and chronic pain, where he spearheads the company's scientific, clinical and technology development efforts, as well as it's fundraising. As an academic vascular surgeon, Dr. Bazan is the John Ochsner Endowed Professor of Surgery in Innovation ( https://www.ochsner.org/doctors/hernan-bazan ). His clinical interests include treating carotid artery disease and acute stroke, using minimally invasive approaches to aortic aneurysms and peripheral arterial disease, and managing acute post-operative pain. Over the years, Dr. Bazan has realized the significant clinical and societal need for safer and non-addictive pain relief in ambulatory and post-operative settings. From these critical unmet needs, South Rampart Pharma, Inc. was founded in 2016 to develop safer, non-opioid therapies for acute and chronic pain.Dr. Bazan authored the first manuscript describing the library of analgesic compounds' synthesis, lack of hepatoxicity analgesic characterization, and antipyretic properties, published in September 2020 in the European Journal of Medicinal Chemistry and a current paper under advanced review (open access) in Nature Communications.Dr. Bazan is the PI or Co-I on two NIH/NINDS STTR (small business commercialization) grants to develop a novel non-narcotic and non-toxic analgesic to safely treat acute, chronic, and neuropathic pain. He is the co-inventor of 7 issued or pending patents and has authored over 50 publications. He and his team have completed Phase 1 clinical trials, paving the way for Phase 2 RCTs in acute and neuropathic pain. He was bestowed the 2024 NIH HEAL Director's Trailblazer Award for this work.Dr. Bazan received a B.S. in Molecular Biology (Vanderbilt University). He spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. He earned an M.D. (Georgetown University), followed by a General Surgery Residency (Mt. Sinai Hospital, New York) and a Vascular Surgery Fellowship (Yale University).#Pain #Opioids #NSAIDS #Acetaminophen #Analgesia #Nociception #PostOperative #HernanBazan #NicolasBazan #SouthRampartPharma #Ochsner #Fentanyl #Aspirin #Ibuprofen   #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

In The Space Business is... – the podcast series of The Space Business is Everywhere campaign, underwritten by ST Engineering iDirect – we take a look at the way the commercial space industry has spread itself to parts of the world where space and satellites were once only read about or dreamed of. Each episode will on a specific location and features an innovator who is shaping - and reshaping - the industry. In the second episode, we hear from Jane Egerton-Idehen, CEO of Nigerian Communications Satellite Limited (NIGCOMSAT). Jane Egerton-Idehen is a seasoned professional Tech Executive, Author and Angel Investor. She is a dynamic executive with over 20 years in leadership roles across telecommunications, technology and satellite industries. She is currently the MD/CEO of Nigerian Communications Satellite Limited (NIGCOMSAT), leading the nation's foremost agency in charge of managing the operations and services of the communications satellite owned by Nigeria. She has previously held high-level positions at Meta, Avan Communications, Ericsson and Nokia Siemens Network. With proven expertise in driving strategic growth, fostering C-level relationships and implementing revenue-generating sales strategies across multi-national markets, Egerton-Idehen is recognized among Nigeria's top corporate leaders, with a focus on emerging markets, strategic consulting and innovative technology solutions. She was the Head of Sales, Middle East and Africa, Meta and Country Manager & Regional Sales Director for the West African branch of Avan Communications Group PLC. She cumulatively spent 13 years in Sales and Management in the telecommunication infrastructure giant — Ericsson. She also worked as a Cluster lead for Nokia Siemens Network in West Africa. Egerton-Idehen was born and raised in Lagos, Nigeria. She has a degree in Electronics Engineering in 2001 from the University of Nigeria, Nusska; a Master's Degree from Warwick Business School, US; and an executive education from Yale School of Management, US. She has worked in the telecommunications industry in Africa for more than 17 years. Being one of the few females heading key business areas in the tech industry has exposed her to numerous professional and personal challenges peculiar to women. Spurred by discussions with fellow female executives round the globe, she organized a forum at Ericsson in which emerging and experienced female leaders could support each other in developing their careers. The overwhelming success of the forum led her to found Women and Career to reach women beyond her organization and to support girls seeking careers after school. In March 2020, she published a book, Be Fearless: Give Yourself Permission To Be You. She drew from her more than 15 years of experience as a telecommunication executive in Africa to help women build lasting careers, especially in the male-dominated STEM industries. Egerton-Idehen has continued to be actively involved in speaking to girls and women about STEM careers. She has spoken at TEDx programs, the African Science Academy, Asheshi University in Ghana, and CFA's Startups Hangout and many more. She was awarded the Most Outstanding Female CEO of 2024 by the 5th Business and Excellence Awards. She is also the recipient of the Womenovate INWED2024 Women Impact Leader Awards. Egerton-Idehen volunteers for the ACE Foundation's Young Career and Graduate Mentorship Programme, and she is an aspiring fellow of the Aspen Global Leadership Institute. A home girl at heart, she actively gives back to the Ajegunle community of Lagos through the Sozo Network's #BeforeITurn18 program, which prepares underserved teenage girls for life, career and leadership.

In this episode Steven Hanks, MD, CEO of St. Joseph's Health, shares how he balances his executive responsibilities with regular clinical shifts in the emergency department. Discover how his hands-on leadership fosters morale, enhances decision-making, and strengthens connections across the organization.

About Dr Adeel Khan, MD - CEO and Founder of Eterna Health Interventional Cell and GeneTherapy Specialist: Dr. Adeel Khan, MD, is a trailblazer in regenerative medicine, transforming how we think about health, longevity, and recovery. As a Canadian Board-Certified Physician, Dr. Khan has pioneered cutting-edge therapies using stem cells and peptides—modalities now making headlines around the globe. Recognized worldwide, Dr. Khan's impact resonates among healthcare professionals, elite athletes, and individuals from diverse walks of life. His groundbreaking treatments have earned him the trust of renowned figures, including celebrities, such as Chris Hemsworth, life coach Tony Robbins, Chris Bumstead (popularly known as “cbum,” a top fitness influencer), and Mohamed Alabbar, the visionary developer behind the iconic Burj Khalifa. Dr. Khan's work is being discussed across major media outlets, with a focus on the potential of stem cell therapies to redefine healthcare. His ability to deliver real results is changing the conversation on what's possible in modern medicine. Dr. Khan's unwavering dedication to understanding cellular physiology and the art of cellular repair has led to collaborations with scientists in Canada, the USA, Mexico, Dubai, Italy, and Japan. These partnerships have helped shape Eterna Health, a revolutionary concept in specialized healthcare offering unparalleled treatment options that stand out in the medical landscape. Connect with Dr. Khan: Website: Eterna Health Instagram: @dr.akhan YouTube: Doctor Adeel Episode Summary: In this episode, Dr. Cassie Smith hosts Dr. Adeel Khan, a Canadian board-certified physician specializing in regenerative medicine, to discuss stem cells. Dr. Khan explains the unique properties of stem cells, particularly mesenchymal stem cells (MSCs), and their potential to treat chronic diseases, aging, and cosmetic issues. The conversation covers the science behind stem cells, their therapeutic applications, and the limitations of conventional medicine. Dr. Khan also addresses ethical concerns, regulatory challenges, and the future of stem cell research, emphasizing the transformative potential of regenerative medicine. Show Highlights: (00:02:35) Frustration with Conventional Medicine (00:04:46) Understanding Stem Cells (00:05:49) The Role of Stem Cells in Healing (00:06:27) Stem Cells and Aging (00:11:34) Clinical Applications of Stem Cells (00:14:54) Common Uses for Stem Cell Treatments (00:16:13) Stem Cells are Transforming Cosmetic Procedures (00:18:36) Stem Cells are the Body's Super Repairman (00:19:00) Smart Stem Cells?? They're Amazing! (00:20:52) Unbelievable Patient Results with Stem Cells (00:24:39) Stem Cells for Healing Autoimmune Conditions (00:29:30) FDA Regulations on Stem Cells (00:39:02) Potential of Stem Cells in Healing (00:46:24) Can Stem Cells Render Transplants Obsolete? (00:52:04) Future of Medicine with Stem Cells Connect with Modern Endocrine: Check out the⁠⁠⁠⁠⁠⁠⁠ ⁠website⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠ Sign up for Modern Endocrine's⁠⁠⁠⁠⁠⁠⁠ ⁠newsletter⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠Disclaimer ⁠⁠⁠⁠

In this episode of "The Brand Called You," Shilpa Pophale, Managing Director of Electronica Finance Limited, shares her groundbreaking insights into MSME financing, rural entrepreneurship, and financial inclusion. With over 30 years of experience, Pophale has transformed her organization from a ₹495 million enterprise to a ₹37 billion powerhouse, pioneering innovative lending strategies that support small businesses across India. 00:34- About Shilpa Pophale Shilpa is the Managing Director and Chief Executive Officer of Electronica Finance Limited.  She was conferred with the Woman Entrepreneur of the Year by the World Women Leadership Congress in 2014. She is also a YPO member. --- Support this podcast: https://podcasters.spotify.com/pod/show/tbcy/support

Send us a textDr. James L. Madara, MD, is CEO and Executive Vice President of the American Medical Association ( https://www.ama-assn.org/about/authors-news-leadership-viewpoints/james-l-madara-md ), the United States' largest physician organization. He also holds the academic title of adjunct professor of pathology at Northwestern University ( https://www.pathology.northwestern.edu/Faculty/profile.html?xid=24099 ).Since taking the reins of the AMA in 2011, Dr. Madara has helped sculpt the organization's visionary long-term strategic plan. He also serves as Chairman of Health2047 Inc. ( https://health2047.com/ ), the wholly-owned innovation subsidiary of the AMA, created to overcome systemic dysfunction in U.S. health care and located in Silicon Valley. Working closely with the AMA, Health2047 finds, forms and scales transformative health care spinout companies in four fields: chronic care, data utility, radical productivity and health care value. Several companies have been launched to date.Prior to the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor, and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following five years as chair of pathology and laboratory medicine at Emory University, Dr. Madara served as dean of both biology and medicine, and then as CEO of the University of Chicago Medical Center, bringing together the university's biomedical research, teaching and clinical activities. While there he oversaw the renewal of the institution's biomedical campus and engineered significant new affiliations with community hospitals, teaching hospital systems, community clinics and national research organizations.Dr. Madara also served as senior advisor with Leavitt Partners, an innovative health care consulting and private-equity firm founded by former Health and Human Services Secretary Mike Leavitt.Having published more than 200 original papers and chapters, Dr. Madara has served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology.In addition to Modern Healthcare consistently naming him as one of the nation's 50 most influential physician executives, as well as one of the nation's 100 most influential people in health care, Dr. Madara has been recognized with several national and international awards. These include the prestigious MERIT Award from the National Institutes of Health, the Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society, and the Mentoring Award for lifetime achievement from the American Gastroenterological Society.Dr. Madara is an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. He also co-chairs the Value Incentives & Systems Action Collaborative of the National Academy of Medicine (NAM), and is a member of NAM's Leadership Consortium for Value & Science-Driven Health Care.#JamesMadara #AmericanMedicalAssociation #AMA #Physicians #Pathology #IntestinalEpithelialPathobiology #MedicalSchool #MedicalEducation #HealthEquity #UniversityOfChicago #SocialDeterminantsOfHealth  #NorthwesternUniversity #Health2047 #VentureCapital #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textDr. Tina Ipe, MD, MPH is Chief Executive Officer at Regen Med Clinic ( https://www.regenmed.vip/ ), a medical practice which provides multi-specialty infusions, cutting-edge treatments such as therapeutic apheresis (plasmapheresis and collections), as well as novel aesthetic treatments, for patients with a variety chronic illnesses. Dr. Ipe is a board-certified physician and clinical researcher. Before entering private practice, she was Chief Medical Officer at the Oklahoma Blood Institute, Associate Medical Director at Houston Methodist Hospital, and  Division Director at University of Arkansas for Medical Sciences (UAMS). She is an expert in the fields of blood disorders, immunology, therapeutic apheresis, blood banking, and transfusion medicine. She has published more than 50 peer-reviewed manuscripts and book chapters.Dr. Ipe received her medical degree from the Medical College of Virginia and completed her residency in clinical pathology and fellowship in transfusion medicine at the Hospital of the University of Pennsylvania. She also has an MPH from Dartmouth.#TinaIpe #BloodDisorders #Blood #Biotherapies #Immunology #TherapeuticApheresis #BloodBanking #TransfusionMedicine #RegenerativeMedicine #TherapeuticPlasmaExchange #ConvalescentPlasma #ExtracorporealPhotopheresis #Parabiosis #Longevity #Aging #HospiceCare #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Send us a textDr. Mehmood Khan, MD is the Chief Executive Officer of Hevolution Foundation ( https://www.hevolution.com/ ), a first of its kind non-profit organization that funds research through grants and provides investments in biotech to incentivize healthspan science across disciplines and borders for the benefit of all. Established by a Saudi Royal Decree, with its headquarters in Riyadh, with additional international hubs to support the expansion and execute the global mission, it's vision is to expand healthy human lifespan for the benefit of all humanity.  Hevolution Foundation aims to be positioned as a global leader, catalyst, partner, and convener, to increase the number of scientists entering the field, to increase the investable opportunities in the field of aging, and to help shape the regulatory and government environment.Dr. Khan also currently serves as the Executive Chairman of Life Biosciences Inc. where he joined the company in April 2019 as the Chief Executive Officer and Board Member. Life Biosciences was founded to advance scientific research and develop innovative new therapies to improve and extend healthy lives for everyone.Dr. Khan previously served as Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, a Fortune 50 company employing upwards of 250,000 employees across 22 brands. At PepsiCo, Dr. Khan played a pivotal role in the company's global R&D efforts to create breakthrough innovations in food, beverages, and nutrition, including the incorporation of healthier and more nutritious offerings across its portfolio. Dr. Khan also oversaw PepsiCo's global sustainability initiatives based on the belief that success in business is inextricably linked to the sustainability of the world we share. Prior to joining PepsiCo, Dr. Khan served as President of Global R&D at Takeda Pharmaceuticals, leading the global efforts of one of the largest pharmaceutical companies in the world by revenue.Before moving into industry, Dr. Khan had a distinguished medical career as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition in Minneapolis, MN.Dr. Khan is currently a member of the Board of Directors of Reckitt Benckiser.Dr. Khan has also served as a board member in Spectrum Health, CorMedix, HemoShear Therapeutics, and Indigo Agriculture.Dr. Khan earned his medical degree from the University of Liverpool Medical School, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a Fellow of the Royal College of Physicians in London and a Fellow of the American College of Endocrinology.#MehmoodKhan #HevolutionFoundation #Healthspan #Lifespan #IntrinsicCapacity #Resilience #Aging #Longevity #Rejuvenation #LifeBiosciences #Endocrinology #GeriatricSyndromes #Nutrition #Xprize #FoodScience #Diabetes #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Welcome to Episode 9 of Season 2 of our Podcast series which is all about Investment Wisdom!

So, it turns out that how we frame failure is far more important than how we manage success, in determining our motivation and our ability to sustain healthful and positive ...

Host Tom Foley invites Dr. John Blair the CEO of MedAllies for the first of a 2 part series on TEFCA and interoperability. MedAllies has recently been designated a QHIN by the ONC Recognized Coordinating Entity (RCE), The Sequoia Project. What does that mean and what value does it bring to healthcare providers? To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Gurus, what an honor it is to have the Honorable Mark Dybul, MD CEO of Renovaro Biosciences, on this episode. Dr. Dybul has had such an amazing career working at some of the highest levels of government agencies. He has led teams solving arguably the biggest health challenges ranging from HIV, Tuberculosis and Malaria. We have such a wide-ranging and informative discussion covering how as a CEO you can be more efficient managing deliverables in parallel and why Africa will become the largest global medical market. Get out your notepads as Dr. Dybul brings amazing information in this episode!      

Clare Bertucio is the chief executive officer of Medicine Mama's Apothecary, a company offering organic skincare and personal care products. BOLDLY PURE VULVA CARE . . **This is not medical advice, just medical education. Please ask your doctor medical questions as they pertain to your specific situation. Educational purposes only. #SkyWomensHealthPodcast #EmpowerHerHealth #PureVulvaCare #SelfCareJourney #BOLDLYPURE #WomankindWellness #HolisticHealthTalks #OrganicSkincare #PersonalCareProducts #InTouchWithYourBody #MedicalEducation #AskYourDoctor #EducationalPurposesOnly Dr. Carolyn Moyers, DO is a board certified OBGYN and Neuromusculoskeletal Medicine physician, and founder of Sky Women's Health, a boutique practice in Fort Worth, Texas. Welcome to the Sky Women community where we are all stronger together. COME SAY HI!!! Instagram: https://www.instagram.com/skywomenshealth https://www.instagram.com/drcarolynmoyers Facebook: https://www.facebook.com/skywomenshealth Email: hello@skywomenshealth.com Sky Women's Health: Https://www.skywomenshealth.com 1125 S Henderson St, Fort Worth, TX 76104 To become a patient: email hello@skywomenshealth.com or call 817-915-9803. Listen to the SKY WOMEN PODCAST here: ITUNES: https://podcasts.apple.com/us/podcast/sky-women/id1541657642  SPOTIFY: https://open.spotify.com/show/79VnnWYtGJwlB7NrjBck7o?si=qWXpiBtPSS6OVOt0ki8EiQ --- Send in a voice message: https://podcasters.spotify.com/pod/show/skywomen/message

Host Justin Barnes aka @theHITAdvisor, talks to David Craig MD the CEO of Spruce Health, a cloud-based healthcare communications company that powers modern, innovative medical care, dedicated to enabling medicine that occurs outside of face-to-face interactions and office visits. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Host David Harlow speaks with A. John Blair III, MD, CEO of MedAllies, one of the first cohort of QHINs recently approved under TEFCA. John had been working on health data issues for decades as a practicing physician, as an IPA leader and as a health data exchange executive, and this represents a leap forward in addressing data access, interoperability and usability. John shares some insights on where we are and where we're going on this continuing journey. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Interview with Alex Underwood, MD/CEO of Empire Energy Group Ltd.Our previous interview: https://www.cruxinvestor.com/posts/empire-energy-asxeeg-technical-analysis-due-diligence-4162Recording date: 26th January 2024Empire Energy controls huge shale gas resources in Australia's Northern Territory, estimated at over 40 trillion cubic feet by independent assessors. With domestic east coast markets facing looming supply shortfalls amid rising global demand, Empire has a clear strategic production roadmap to monetize these world-scale gas assets.Initially focussed on oil and gas production in the US, Empire pivoted towards acquiring and proving up acreage in the vast onshore Beetaloo Basin after capitalizing on the US shale boom's early stages. Australia's Beetaloo region shares similar shale geology and Empire moved swiftly to build a dominant position. Few companies boast more prime shale acres.Having confirmed world-class volumes of gas in place via drilling vertical and horizontal test wells, Empire is fast-tracking low cost pilot schemes. An initial 3 well development campaign with 60 stage hydraulic fracturing aims to flow test production potential. Early success would derisk substantial follow-on development, likely attracting industry interest.Empire has accelerated pilot production plans by acquiring a second-hand gas facility for a bargain $3 million. Refurbishing this will expedite on-site infrastructure assembly. Along with advanced talks on securing gas sales agreements, first cash flow now looks possible inside 12 months.Beyond pilot schemes, Empire has a multi-stage production growth plan. Phase one fills spare capacity in an existing pipeline traversing Empire's permits. Rapidly expanding output from 25 million cubic feet per day to feed Darwin's energy shortfall would generate over $100 million annual revenue. Subsequent phases look to ramp up production, ultimately targeting 1 billion cubic feet daily for southern LNG exports. Attractive economics expected from initial wells provides cashflow to fund each organic development stage.From an early entry point, Empire Energy offers leveraged exposure to realization of the Beetaloo Basin's full potential. Key de-risking milestones are approaching fast. Cash flow and resource appraisal progress could spotlight Empire's world-scale gas resource. Its disciplined step-by-step commercialization strategy aims to capitalize on strengthening gas market conditions. Targeting first production within 12 months provides investors a near term catalyst.—View Empire Energy Group's company profile: https://www.cruxinvestor.com/companies/empire-energy-groupSign up for Crux Investor: https://cruxinvestor.com

The Pharmacy Podcast Network is proud to bring you healthcare and business information from our trusted source and monthly guest, Dr. Gail Lebovic.  We're covering important topics and bringing health and wellness to your community by bridging the gap between pharmacies, physicians and patients.   This monthly podcast is sponsored by Silicon Valley Innovations, makers of NasoClenz. The time of year is upon us when blistering heat gives way to colder weather.  With the change of seasons come a multitude of challenges for the nose, sinuses and lungs.  Allergens, dust, air pollution, particulate matter in the air, changes in barometric pressure and respiratory viruses can all wreak havoc on our respiratory systems leading to nasal congestion, post nasal drainage, coughing, wheezing, fatigue and eventually sinusitis and even pulmonary infections such as bronchitis.      Join our host Todd Eury as we welcome our guests live from the floor at the American Academy of Otolaryngology Head and Neck Surgery Annual Meeting in Nashville, TN    Keith Matheny, MD - Medical Entrepreneur & Otolaryngologist Gail Lebovic, MD - CEO & Founder of Silicon Valley Innovations and creator of NasoClenz

Join us for a captivating episode of the Becker's Healthcare podcast featuring Dr. Hilton M. Hudson, a board-certified cardiothoracic surgeon and Chief of Cardiothoracic Surgery at Franciscan's Michigan City and Olympia Fields health systems, as well as the CEO of HPC International Inc. Dr. Hudson shares his unique insights on the healthcare industry, discussing the critical issue of personnel shortages and labor tension while delving into the origins and mission of HPC International. He also reflects on the journey towards health equity and the evolving dynamics of leadership in healthcare. Don't miss this engaging conversation with a seasoned healthcare leader who has made a significant impact on the industry.

On this special Fireside Chat, HFS CEO and Chief Analyst Phil Fersht is in conversation with Mohit Joshi, Managing Director and CEO Designate at Tech Mahindra about his personal and digital business journey. With over two decades of experience in enterprise technology software and consulting, Mohit has worked with the largest corporations in the world in driving digital transformation and building thriving businesses. He has been a Non-Executive Director at Aviva Plc since 2020 and is a member of its risk and governance and nomination committees. Prior to joining Tech Mahindra, Mohit was President of Infosys Limited. He started his career in banking with ABN AMRO and ANZ. Phil and Mohit cover a range of topics, including: Before we get into the industry talk, can you share a bit about your background? Also, have you always wanted to lead a huge global technology business? Who's been your main influence during your inexorable career rise? So, this brings us to Tech Mahindra – taking over a heritage business like this during a major time of change in our industry is a huge challenge – what will you bring to the table? You've been one of the major faces of financial services over the past decade-plus and now you've joined a company that leads in the telecom sector, so how do you plan to grow the industry focus in Tech M? Can you compete in BFS with the leaders, or will this take time? Are you enthusiastic or scared about AI? Why? How do you see software and services being impacted by GenAI? Can the current crop of leading firms change their products and delivery models to stay relevant? Do you believe white-collar jobs are under threat with Gen-AI? Do you believe our education system is going to be rocked with so many kids using it for their coursework Finally, if you had one wish for the IT services industry, what would that be?

This episode featured Princess Funlayo Bakare-Okeowo, MD/CEO of FAE Ltd, the largest envelope manaufcturing company in Nigeria. Princess Funlayo has over 40 years experience in the manufacturing sector. She was interviewed by Chidiebere Nnorom, Founder/CEO, Paperbags by Ebees, an eco-friendly packaging company. We are certain that you will be inspired by their journeys in Entrepreneurship in the manufacturing space. Don't forget to share your feedback, comments and experience with us in the comment section.

As we journey towards net-zero emissions by 2050, energy crises around the world are on the rise, pointing to the inevitable need for hydrocarbons as we transition. Africa is rich in hydrocarbons, so how can the continent secure global energy demand with its resources? To find out, Business Day TV spoke to Adeg-bite Falade, MD & CEO of Aradel Holdings.

Another fruitful day of news to analyse, with the revolving door at Fortescue (FMG) again being a talking point as two further senior figures leave the company. We then delve into the Bald Hill debacle, which appears to have an imminent end to it, with a mysterious bidder for the prized asset lurking. A quick mention for Sayona (SYA) and Morella (1MC), who share an MD/CEO, then onto a deep dive into AuTECO's $50m acquisition of the Green Bay Copper-Gold project in Eastern Canada. We round off the week with more news out of Canada as uranium developer NexGen (NXG) announces funding via a US$110m convertible note. All Money of Mine episodes are for informational purposes only and may contain forward-looking statements that may not eventuate. The co-hosts are not financial advisers and any views expressed are their opinion only. Please do your own research before making any investment decision or alternatively seek advice from a registered financial professional. Thank you to our Podcast Partners:Terra Capital – Specialist Investment manager in the natural resources sectorAnytime Exploration Services – Exploration workers, equipment, core cutting/storage + much moreJP Search – Recruitment specialists for the financial worldK-Drill – Safe, reliable, and productive surface RC drillingTopdrill – Drilling into the future Join our exclusive Facebook Group for the Money Miners and request access to the Hooteroo chat group. Subscribe to our weekly newsletter HOOTEROO HERALD Follow Money of Mine on YouTubeFollow Money of Mine on TwitterFollow Money of Mine on LinkedInFollow Money of Mine on Instagram Chapters:(0:00) Preview(0:41) Intro(3:07) The Revolving Door at Fortescue Continues(12:55) Alita's Bald Hill to be Changing Hands Imminently!(20:54) Sayona & Morella's Busy CEO(23:36) AuTECO Scoop up Canadian Copper Asset(37:32) NexGen Secure Convertible Debt Funding

Friends, In my upcoming book, Beyond The Walls, I spend an entire chapter discussing how platforms have revolutionized other industries and how they're about to do the same in healthcare.  ...

The local property market has taken a knock, with the SA Listed Property Index slipping 7.4% in the second quarter. Business Day TV caught up with MD & CEO of Rode Associates, Erwin Rode for a look at the factors weighing on the industry.

A need for actionable insights has held back healthcare, but better health outcomes can come with innovative analytics and incentives. In this episode, Jean Drouin, Founder and CEO of Clarify Health, talks about making a system-level impact in healthcare by using data insights to smooth everyone's journey in the care setting. He explains how Clarify Health provides clinicians with the tools they need to keep patient satisfaction high and avoid burnout, coming full circle with the goals he set himself from the very beginning of his career. Tune in to learn how information can lead to a better healthcare industry and empowered patients! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Host Dr. Nick van Terheyden aka Dr. Nick, discusses Integrated Virtual Care with Lyle Berkowitz, MD, CEO of Keycare. Their discussion includes Lyle's long career in medicine and the intersection of business and technology, being CMIO and clinician at Northwestern Medicine in Chicago, helped build early innovation centers for healthcare, and more. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio.” Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On Episode 9 , I spoke with Shiv Rao. Dr. Rao is the founder and CEO of Abridge, which uses ambient AI to summarize conversations into clinical documentation. He is also a practicing cardiologist, and previously led the provider-facing investment portfolio for UPMC. “What did the doctor say?" is inevitably the first question we ask a loved one who has just been to see a clinician. But how often do we get a clear answer ? How many of our loved ones are actually knowledgeable enough to grasp the details of their condition/diagnosis/care plan? Research out of Dartmouth suggests that people forget up to 80% of what they've heard from their healthcare professional. That's what makes Abridge so important, and is likely the reason that over 300,000 people are using the free version of the Abridge app (which you can download here on the app store) to help make sense of medical conversations and share information from clinical consultations with loved ones.As Dr. Rao pointed out in our conversation, there is a public health emergency occurring in the United States - we do not have the supply of clinicians necessary to meet the demands for care delivery. Compounding a lack of clinicians is an uptick in burnout. The AMA currently estimates that physician burnout is at 63%, and an article in the Journal of Internal Medicine that said clinicians would need 27 hours per day to do all the work that's required of them. Shiv started Abridge to reduce the documentation burden on physicians, and to provide patients with a digestible, “translated” version of their clinical encounter that they can share with family members.  The benefits are also significant for clinicians. Over 80% of the clerical work that used to be involved in documenting is now getting automated by Abridge - this solution is currently saving clinicians on the platform an average of 2 hours a day! Ultimately, as we discussed, a clinical note has three stakeholders:Other clinicians on the care team - they need to understand Dr. Rao's medical differential, and how he was thinking about the diagnosis/care plan.Health plans - Dr. Rao needs to build his note in such a way that the diagnosis and follow-up recommendations can be properly coded and billed.Patients and their family members, who may need to take action based on Dr. Rao's findings, which they thus need to understand.A single note cannot be all of those things at once. Abridge solves this problem by summarizing and structuring the information to create different artifacts for all three sets of customers.Abridge has raised $27 million to date from investors like Union Square Ventures, Bessemer Venture Partners, and Wittington Ventures. For more information,  you can check out their website: https://www.abridge.comPlease make sure to check out the Society for HealthCare Innovation's (SHCI) website for more content. 

April 27: Today on the Conference channel, it's an Interview in Action live from ViVe 2023 with Ali Rahimi, MD, CEO & Founder of ALYKA Health Technologies. What inspired Ali to create ALYKA Health, and how did he recognize the gaps in healthcare that his platform addresses? What specific data elements are included, and how is this information used to target education and improve engagement? What is the goal of the health resilience index, and how does it help improve health outcomes? How do they use a multimedia approach to make healthy behaviors more enjoyable for users?Join us on May 4 at 1PM ET for our webinar: 'Leader Series: Modern Data Strategies in Healthcare.' This webinar will focus on exploring data governance and analytics strategies that have the potential to revolutionize healthcare in the modern era. With a data-driven approach, we can improve patient care outcomes, increase efficiency, and reduce costs in the healthcare industry. Register Here: https://thisweekhealth.com/modern-data-strategies/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Jonathan Baktari MD brings over 20 years of clinical, administrative, and entrepreneurial experience. He has been a triple board-certified physician with specialties in internal medicine, pulmonary, and critical care medicine.Dr. Baktari was formerly the Medical Director of The Valley Health Systems, Anthem Blue Cross Blue Shield, and Culinary Health Fund. He also served as clinical faculty for several medical schools, including the University of Nevada and Touro University.Learn more: https://jonathanbaktarimd.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-jonathan-baktari-md-ceo-of-e7-health-and-us-drug-test-centers

Jonathan Baktari MD brings over 20 years of clinical, administrative, and entrepreneurial experience. He has been a triple board-certified physician with specialties in internal medicine, pulmonary, and critical care medicine.Dr. Baktari was formerly the Medical Director of The Valley Health Systems, Anthem Blue Cross Blue Shield, and Culinary Health Fund. He also served as clinical faculty for several medical schools, including the University of Nevada and Touro University.Learn more: https://jonathanbaktarimd.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-jonathan-baktari-md-ceo-of-e7-health-and-us-drug-test-centers

We don't often hear from a physician executive. When we do, I always appreciate their unique perspective. Physician executives have on-hands experience as a practitioner as well as an administrator. With us today is Dr. Craig Samitt who is the new CEO of the National Physician Enterprise for Surround Care which is the formation of two prominent organizations in Navvis Health a population health management company and Esse Health large multi-specialty group practice in St. Louis, MO. Craig's unique background affords him a broad view of the healthcare ecosystem. Craig was previously the CEO pf BCBSMN, and currently serves as the managing director for a venture firm. Craig has also worked in Clinical and leadership roles at Anthem, Healthcare Partners, Oliver Wyman and more. I have followed his career and am excited to have him with us today to share his perspective on industry challenges and changes.

Interview with Brandon Munro, MD/CEO, and Gavin Chamberlain, COO of Bannerman Energy (ASX: BMN).Bannerman Energy is an Australian listed uranium development company. Their flagship Etango Project is one of the world's largest undeveloped uranium assets. It is located in the highly established uranium mining jurisdiction of Namibia and they have environmental permits in place for development. Etango has been strongly de-risked through extensive drilling, technical evaluation and operation of a process demonstration plant facility.

S2E10: Civil War Medicine with Jon Bloom, MD, CEO & Co-Founder of Podimetrics and host Dr. Nick. We are living longer and healthier lives in the current times. But we are facing some rising challenges to the general health of the population. This is especially true in the US where declining number of health population metrics includes life span. And is contrary to other developed nations seeing continued improvements. On this episode, the silent killers, diabetes. Your better pill to swallow is to enable the delivery of prevention and care out in the community and the home. Empower patients to be fully engaged in their own wellness. Catch disease before it presents as a serious clinical condition and enable your patients to stay healthier. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

“Don't let other people control your agenda or the dynamics of your diary. I don't have any qualms saying to people that I'm postponing meetings and focusing on five things that are going to move the dial.” In this Best of Series episode, we hear from former MD & CEO of The Pact Group, Mal Bundey, on making a difference and bringing your ‘A Game'.

In this episode, I sat down with Iman Abuzeid, MD, CEO and Co-Founder of Incredible Health. Founded in 2017, Incredible Health, the highest valued tech-enabled career marketplace in healthcare, transforms the hiring process for both nurses and health systems. In August 2022, Incredible Health raised an $80M Series B round led by Base10 Partners. The company partners with over 600 top health systems across the country, has over 10,000 nurses joining its platform every single week, and has reduced the average timeline for hiring a nurse from 82 days to less than 14. Iman and I discuss: 1) her background in medicine and how she became a startup founder in the healthcare ecosystem, 2) the current nurse staffing crisis that's on track to leave the US 1M nurses short by the end of 2023 and how we got here, 3) how Incredible Health is reducing nurse burnout, improving retention, and empowering hospitals to set up their nursing workforces for career advancement, and 4) Iman's evolution as a leader and how she has invested in herself and her team to keep up with the company's growth.

In this episode, we chat with Greg Cochran, MD of Aurora Energy Metals. It is an Australian-owned company focused on the exploration and development of its Aurora Energy Metals Project in Oregon, USA. The project hosts a defined uranium resource and is prospective for lithium. Greg is a highly regarded international mining executive with over 30 years of experience in general management and in senior commercial and technical roles. With a background in mine engineering, he has operated at the MD/CEO level for the last 15 years, in Africa, Australia and Asia, in a broad spectrum of minerals including uranium, potash and other industrial minerals and base metals. He tells us more about Aurora Energy Metals and discusses, in more depth, the uranium market which is his expertise.Greg is also going to be speaking at the upcoming Mines and Money event in London at the end of November 2022. So, be sure to reach out to him there in person if you have any further questions. Enjoy the episode. KEY TAKEAWAYS There is a uranium revival on the way. Energy security is fundamental and the benefits of nuclear are being recognised. Their Oregon project is one of the largest uranium projects in the US. Mining uranium at scale is far more environmentally sustainable than the old approach of hundreds of small operations. Having both lithium and uranium to mine provides Aurora with the ability to pivot between the two. The mineral Acts that have been passed by Biden are supportive of minerals, which is good news for Aurora Energy Metals. There is the potential for state funding. The site can tap into a renewable energy source, which is extremely cheap as well as clean. Potentially a pipeline or conveyor can be used to get the ore to Nevada for processing. Transportation solutions that have an exceptionally low impact on the environment. BEST MOMENTS‘produce for 10 to 50 years 1.5 to 2 million pounds of uranium. ´‘Countries are recognising nuclear energy's benefits as we recognise renewables benefits.'‘Number 1 it´s (renewable energy) cost-effective. Number 2 it's clean, it's zero emissions.' EPISODE RESOURCESWebsite: https://auroraenergymetals.com/FOLLOW US ON TWITTER: https://twitter.com/Aurora_1AEFOLLOW US ON LINKEDIN: https://www.linkedin.com/company/aurora-energy-metals “Resourcing Tomorrow” is Europe's largest and most in-depth mining conference dedicated to global sustainability goals and is coming to London this November. This Mines and Money event will be held at the Business Design Centre from the 29th of November to the 1st of December.Companies like Rio Tinto, Alcoa, Barrick, Ma'den, and Anglo American are attending alongside 2000 other decision-makers, mining leaders, policymakers, investors, innovators, and educators from 75+ countries for three days of learning, deal-making and unparalleled networking. It gives you a chance to see what the majors and juniors are forecasting heading into next year and you are able to catch up with other like-minded professionals in the industry.“Book your tickets now at resourcingtomorrow.com and use code DIGDEEP10 to receive 10% off your pass. VALUABLE RESOURCESmailto:rob@mining-international.orghttps://www.linkedin.com/in/rob-tyson-3a26a68/http://www.mining-international.orghttps://twitter.com/MiningConsulthttps://www.facebook.com/MiningInternational.orghttps://www.youtube.com/channel/UC69dGPS29lmakv-D7LWJg_Q?guided_help_flow=3 ABOUT THE HOSTRob Tyson is the Founder and Director of Mining International Ltd, a leading global recruitment and headhunting consultancy based in the UK specialising in all areas of mining across the globe from first-world to third-world countries from Africa, Europe, the Middle East, Asia, and Australia. We source, headhunt, and discover new and top talent through a targeted approach and search methodology and have a proven track record in sourcing and positioning exceptional candidates into our clients' organisations in any mining discipline or level. Mining International provides a transparent, informative, and trusted consultancy service to our candidates and clients to help them develop their careers and business goals and objectives in this ever-changing marketplace. CONTACT METHODrob@mining-international.orghttps://www.linkedin.com/in/rob-tyson-3a26a68/ Podcast DescriptionRob Tyson is an established recruiter in the mining and quarrying sector and decided to produce the “Dig Deep” The Mining Podcast to provide valuable and informative content around the mining industry. He has a passion and desire to promote the industry and the podcast aims to offer the mining community an insight into people's experiences and careers covering any mining discipline, giving the listeners helpful advice and guidance on industry topics.See omnystudio.com/listener for privacy information.

In this fireside chat recorded at CMO Summit 2022, Drs Alise Reicin and Marcella Ruddy discuss what makes their collaboration work and advice on what not to do as an MD CEO and CMO. Speakers: Alise Reicin, MD, CEO & President, Tectonic TherapeuticMarcella Ruddy, MD, CMO, Tectonic Therapeutic

Tune into this episode with the Chief Executive Officer of North American Partners in Anesthesia (NAPA), John F. Di Capua, MD. In this conversation we talk about how the No Surprises Act and IDR process are impacting access to healthcare, and what we can do about the long and short-term staffing shortage. This episode is sponsored by North American Partners in Anesthesia.

In this session recorded at CMO Summit 2021, hear from Dr Ron Cohen about his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen also shares advice on how CMOs can best collaborate with their CEOs and add value to their companies. Speakers: Ron Cohen, MD, Founder, President & CEO, Acorda TherapeuticsKen Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine /Founder and Board Chair, CISCRP

n this week's episode of Entrepreneur Rx, John has the pleasure of interviewing Dr. Andrew Le, CEO and cofounder of Buoy Health, a Boston-based digital health company that uses AI technology to provide personalized clinical support. Andrew tells us the story of Buoy's foundation, his entrepreneurial journey within healthcare, taking a leap of faith when not following the traditional physician journey, and starting a business from the ground. He also encourages aspiring healthcare entrepreneurs to not let their own thoughts put them down; if they have an idea worth fighting for, go ahead and explore it!

It's inventors week on SleepTech Talk with Dr. William Noah! Dr Noah has invented a revolutionary device to make CPAP more comfortable for patients and increase adherence. The V-Com, which softens peak inspiratory flow, makes starting CPAP easier and faster. V-Com is an accessory added between the CPAP mask and the CPAP hose that is specifically engineered to reduce inspiratory pressure and flow to provide comfort with minimal to no reduction in expiratory pressure (EPAP). Since V-Com has minimal effect on EPAP, there is minimal effect on therapy. After weeks or months when the patient can easily tolerate the peak flow and inspiratory pressure of PAP therapy, the V-Com can be removed from the circuit. Join us as we learn more about this new tool that can help our patients tolerate PAP therapy and improve overall adherence! To learn more or to request a free sample of the V-Com - https://sleepres.com/v-com/ Intro music Pierce G. Mann Sound Diego R. Mann

K. Khanal is a film director, writer, cinematographer, and producer best known for his work on the Pashupati Prasad and Chapali Height franchises, as well as the MD/CEO of D.S. Digital Productions. In this episode of On Air, we discuss travelling to Mars, the power of Pashupati, Chapali Height, aliens and spacecraft, the Kagbeni movie, recipe for hit movies, Netflix, and more of his future plans. And if you haven't seen his latest film 'Chiso Manchey', you should!

Friends, Just about every major industry, with the exception of healthcare, has moved into the digital era. This is not my opinion alone. It is the collective perspective of the ...